Navigation Links
PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
Date:6/1/2009

. Additional clinical programs include the development of CCX140, which targets the CCR2 receptor, currently in a Phase I clinical trial and intended for subsequent development to treat diseases such as Type 2 diabetes, multiple sclerosis and vascular restenosis, and CCX354, a CCR1 antagonist in a Phase I clinical trial, being developed for inflammatory diseases such as rheumatoid arthritis. ChemoCentryx also has several programs in preclinical development. ChemoCentryx is privately held. For more information, please refer to www.chemocentryx.com.

Any statements in this press release about ChemoCentryx's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as may, believe, will, expect, anticipate, estimate, intend, predict, seek, potential, continue, plan, should, could and would or the negative of these terms or other comparable terminology. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implement
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
2. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
5. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
6. TNFerade(TM) Phase III Data Presented at ASCO
7. Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
10. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
11. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... SM , the nation,s leader in medication monitoring solutions, ... M.D., as Chief Medical Officer. In this role, Smith ... healthcare providers, patients and managed care plans.   ... of healthcare companies that have provided him with experiences ... sides of Ameritox,s business. He most recently served as ...
(Date:10/17/2014)... 17, 2014   ndd Medical Technologies , a ... precise ultrasound technology, announced that its EasyOne Pro® is ... Center , a 140,000 square foot, 44-bed hospital with ... hospital serves a large number of Native Americans ... and beyond. A portion of its funding ...
(Date:10/17/2014)... Calif. , Oct. 17, 2014  STAAR Surgical Company ... of implantable lenses and delivery systems for the eye, today ... Investor Breakfast Meeting on Saturday, October 18, 7:00 a.m. CT ... Chicago, IL. Dr. ... Eye Centre in Antwerp, Belgium , will ...
Breaking Medicine Technology:Ameritox Appoints New Chief Medical Officer 2EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 3
... VIEW, Calif., May 1, 2012 MAP Pharmaceuticals, Inc. (Nasdaq: ... the following investor conferences in May 2012: Deutsche Bank ... in Boston Bank of America Merrill Lynch 2012 Healthcare ... A live webcast of each event will be available ...
... May 1, 2012 /PRNewswire-iReach/ -- GenWay Biotech ... company,s new Vice President of GenWay Custom/OEM. This position ... focus on growth of the individual divisions including GenWay ... Biotech has provided the diagnostic and research communities with ...
Cached Medicine Technology:GenWay Biotech Appoints New Vice President of Custom/OEM 2GenWay Biotech Appoints New Vice President of Custom/OEM 3
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has ... GreenGeeks are the best Dedicated Server Hosting suppliers. ... want to buy high quality hosting and save ... manager of Top10BestSEOHosting.com says, “We believe that iPage ... everyone. A lot of the global clients enjoy ...
(Date:10/19/2014)... This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ... late-stage and discontinued projects. , Partial Seizures are ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Stephen T. Greenberg, ... been nominated for the 10th consecutive year as one of ... Dr. Greenberg was also been nominated as the best provider ... also nominated as best Day Spa and best Laser Treatment ... December 14th and readers can vote for the contest once ...
(Date:10/19/2014)... 20, 2014 – The U.S. Government has initiated ... Alzheimer,s disease by 2025. However, a workgroup of ... research milestones in the U.S. Government,s National Plan ... scope, increased in scale, and adequately funded in ... of proposals by the workgroup to enlarge and ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... Thermage, Inc.,(Nasdaq: THRM ), today announced ... Medical, Ltd., a leading distributor of advanced aesthetic,technology ... sales professionals will market the Company,s ThermaCool(R) systems,and ... United States. "We are very pleased to ...
... ... Brussels, HUNTERSVILLE, N.C., Oct. ... it has,acquired the rights to all of the intellectual property related to ... and back pain suffered by,individuals with lumbar spinal stenosis (LSS). The innovative ...
... In people with chronic myeloid leukemia (CML), the drug ... but the disease often returns when treatment is stopped. ... could cure CML under certain circumstances if it is ... Mathematician Natalia Komarova and biologist Dominik Wodarz also developed ...
... Majority Leader Harry Reid issued the following statement this,afternoon ... legislation:, "This afternoon, the Congress sent to President ... nation,s children. It is our hope and the will,of ... bill into law on,behalf of the future. It is ...
... Oct. 2 CYNACON/OCuSOFT (OCuSOFT,Inc.), a company ... ophthalmologists and optometrists, is pleased to announce ... its Optometric Scientific,Advisory Board. *(LOGO: Send2Press.com/mediaboom/07-0803-Occusoft_72dpi.jpg) ... of Omni Eye Surgery in New York,City. ...
... 3 With declining revenues and,shrinking sales forces, ... Affairs, to maximize their sales support role, yet ... goal, leading pharmaceutical,companies run sleek and efficient Medical ... function, thereby ensuring the creation of,winning products. ...
Cached Medicine News:Health News:Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd. 2Health News:Orthofix International Acquires InSWing(TM) Interspinous Process Spacer 2Health News:Orthofix International Acquires InSWing(TM) Interspinous Process Spacer 3Health News:Drug has ability to cure type of leukemia 2Health News:Medical Affairs: Building Efficient Medical Affairs Functions That Drive Product Marketing Success 2
Bravo Datalink. For upload of Bravo pH data to a PC. Connects to the pcs serial port....
Bravo Calibration Tubes...
pH Calibration Stand with two Sealable Buffer Tubes 1 set....
... catheters are efficient, economical, eliminate the ... patient comfort during the test period., ... have been designed to use temperature ... room-temperature calibration. The temperature correction factors ...
Medicine Products: